AOD-9604
Modified C-terminal fragment of human growth hormone, residues 176 to 191
7 papers · 2000–2017 · 5 journals
What the research explores
Interest in AOD-9604 stems from a structural question: which activities of growth hormone are carried by the C-terminal fragment, and which require the intact protein. Published preclinical work explores:
- Lipid-metabolism signalling in isolated adipocyte and cell-culture systems
- Comparison of fragment behaviour against full-length growth hormone at the GH receptor
- Whether the fragment acts through pathways independent of the GH receptor
- Stability and degradation profiles of the shortened sequence relative to the parent hormone
These describe laboratory research topics, not outcomes. Elements DNA makes no claim regarding effects in humans or animals and supplies this material exclusively for in vitro and preclinical use.
References
A reference list, not evidence. Inclusion means a paper discusses the compound — not that it supports any use, and not that it describes this product.
2017
- Human sports drug testing by mass spectrometry
Schänzer W, Thevis M
Mass spectrometry reviews
- Human sports drug testing by mass spectrometry
2016
- Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry
Thomas A, Görgens C, Guddat S, et al.
Journal of separation science
- Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry
2015
- Detection and in vitro metabolism of AOD9604
Cox HD, Smeal SJ, Hughes CM, et al.
Drug testing and analysis
- Detection and in vitro metabolism of AOD9604
2014
- Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604
Vanhee C, Moens G, Deconinck E, et al.
Drug testing and analysis
- Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604
2013
- AOD-9604 does not influence the WADA hGH isoform immunoassay
Orlovius AK, Thomas A, Schänzer W, et al.
Drug testing and analysis
- AOD-9604 does not influence the WADA hGH isoform immunoassay
2004
- AOD-9604 Metabolic
Wilding J
Current opinion in investigational drugs (London, England : 2000)
- AOD-9604 Metabolic
2000
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone
Ng FM, Sun J, Sharma L, et al.
Hormone research
- Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone
More research in metabolic
For laboratory and research use only · Not for human or veterinary consumption · Not evaluated by the FDA